Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chromatin Assembly and Disassembly | 27 | 2023 | 634 | 7.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 20 | 2024 | 727 | 6.280 |
Why?
|
Chromatin | 26 | 2024 | 2961 | 3.070 |
Why?
|
Transcription Factors | 37 | 2024 | 12129 | 2.800 |
Why?
|
Sarcoma, Synovial | 6 | 2021 | 153 | 2.470 |
Why?
|
Nucleosomes | 8 | 2023 | 487 | 1.900 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2022 | 1609 | 1.720 |
Why?
|
Multiprotein Complexes | 6 | 2023 | 1120 | 1.330 |
Why?
|
Mammals | 10 | 2023 | 1132 | 1.300 |
Why?
|
Nuclear Proteins | 14 | 2023 | 5799 | 1.140 |
Why?
|
Rhabdoid Tumor | 2 | 2018 | 210 | 1.040 |
Why?
|
Nobel Prize | 1 | 2024 | 48 | 0.930 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2024 | 8552 | 0.870 |
Why?
|
Disease | 2 | 2020 | 672 | 0.860 |
Why?
|
Neoplasm Proteins | 5 | 2020 | 3617 | 0.810 |
Why?
|
Liposarcoma, Myxoid | 1 | 2022 | 60 | 0.790 |
Why?
|
DNA-Binding Proteins | 11 | 2023 | 9610 | 0.730 |
Why?
|
Adenosine Triphosphatases | 3 | 2021 | 836 | 0.720 |
Why?
|
Heterochromatin | 3 | 2017 | 293 | 0.690 |
Why?
|
Histones | 6 | 2022 | 2580 | 0.660 |
Why?
|
Models, Molecular | 5 | 2022 | 5439 | 0.640 |
Why?
|
Neoplasms | 12 | 2024 | 22173 | 0.640 |
Why?
|
Ubiquitins | 1 | 2020 | 366 | 0.630 |
Why?
|
Proto-Oncogene Proteins | 4 | 2020 | 4513 | 0.610 |
Why?
|
Repressor Proteins | 3 | 2020 | 2986 | 0.610 |
Why?
|
HEK293 Cells | 8 | 2020 | 4280 | 0.600 |
Why?
|
Sarcoma | 3 | 2018 | 1801 | 0.600 |
Why?
|
Lymphoma | 6 | 2013 | 1901 | 0.580 |
Why?
|
Genetic Fitness | 1 | 2018 | 115 | 0.560 |
Why?
|
Lifting | 1 | 2016 | 55 | 0.510 |
Why?
|
Developmental Biology | 1 | 2016 | 79 | 0.510 |
Why?
|
Cell Line, Tumor | 18 | 2024 | 16986 | 0.510 |
Why?
|
Protein Subunits | 4 | 2021 | 943 | 0.490 |
Why?
|
p300-CBP Transcription Factors | 1 | 2016 | 150 | 0.490 |
Why?
|
Granulocytes | 1 | 2017 | 551 | 0.490 |
Why?
|
Meningeal Neoplasms | 2 | 2022 | 1248 | 0.480 |
Why?
|
DNA Helicases | 7 | 2023 | 851 | 0.480 |
Why?
|
Protein Interaction Mapping | 1 | 2018 | 616 | 0.470 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 305 | 0.440 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2013 | 694 | 0.440 |
Why?
|
Meningioma | 1 | 2022 | 1218 | 0.430 |
Why?
|
Serine Endopeptidases | 1 | 2018 | 1023 | 0.430 |
Why?
|
Soft Tissue Neoplasms | 2 | 2020 | 1159 | 0.420 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2016 | 682 | 0.400 |
Why?
|
Complement Activation | 1 | 2013 | 445 | 0.390 |
Why?
|
Animals | 38 | 2024 | 168467 | 0.380 |
Why?
|
Protein Binding | 8 | 2021 | 9353 | 0.360 |
Why?
|
Central Nervous System Neoplasms | 3 | 2013 | 916 | 0.350 |
Why?
|
Mutation | 11 | 2023 | 30054 | 0.340 |
Why?
|
Genome, Human | 2 | 2019 | 4425 | 0.320 |
Why?
|
Enhancer Elements, Genetic | 4 | 2019 | 1363 | 0.310 |
Why?
|
Adenosine Triphosphate | 4 | 2022 | 1989 | 0.300 |
Why?
|
Epigenesis, Genetic | 4 | 2024 | 3801 | 0.300 |
Why?
|
Hematopoiesis | 1 | 2017 | 2050 | 0.290 |
Why?
|
Humans | 60 | 2024 | 761572 | 0.260 |
Why?
|
SOXB1 Transcription Factors | 2 | 2021 | 286 | 0.260 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2297 | 0.240 |
Why?
|
Haploinsufficiency | 2 | 2024 | 337 | 0.240 |
Why?
|
Chemistry | 1 | 2024 | 347 | 0.240 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2012 | 1374 | 0.230 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2024 | 223 | 0.230 |
Why?
|
Cell Proliferation | 6 | 2024 | 10448 | 0.230 |
Why?
|
RNA Interference | 4 | 2019 | 2832 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 3 | 2020 | 2803 | 0.200 |
Why?
|
Oncogenes | 3 | 2021 | 1222 | 0.200 |
Why?
|
Virus Internalization | 2 | 2023 | 497 | 0.200 |
Why?
|
Prostatic Neoplasms | 3 | 2018 | 11122 | 0.190 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4319 | 0.190 |
Why?
|
Mutation, Missense | 2 | 2020 | 2571 | 0.190 |
Why?
|
Gene Knockdown Techniques | 2 | 2018 | 1612 | 0.190 |
Why?
|
Genes, Tumor Suppressor | 2 | 2017 | 1062 | 0.190 |
Why?
|
Structural Homology, Protein | 1 | 2020 | 87 | 0.180 |
Why?
|
Histone Code | 1 | 2021 | 158 | 0.180 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 303 | 0.170 |
Why?
|
Brain Neoplasms | 4 | 2009 | 9031 | 0.170 |
Why?
|
Epidermal Growth Factor | 1 | 2022 | 702 | 0.170 |
Why?
|
DNA | 4 | 2022 | 7213 | 0.170 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2024 | 423 | 0.170 |
Why?
|
Gene Knockout Techniques | 2 | 2020 | 802 | 0.160 |
Why?
|
Spliceosomes | 1 | 2019 | 130 | 0.160 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2018 | 67 | 0.160 |
Why?
|
Adenovirus E1A Proteins | 1 | 2018 | 74 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17904 | 0.160 |
Why?
|
Carcinoma, Medullary | 1 | 2019 | 115 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2013 | 9280 | 0.150 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2018 | 161 | 0.150 |
Why?
|
Brachytherapy | 1 | 2005 | 1223 | 0.150 |
Why?
|
BRCA1 Protein | 1 | 2024 | 1158 | 0.150 |
Why?
|
Mutant Proteins | 1 | 2019 | 491 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2018 | 315 | 0.140 |
Why?
|
Catalysis | 1 | 2019 | 774 | 0.140 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2017 | 104 | 0.140 |
Why?
|
Genes, Essential | 1 | 2018 | 185 | 0.140 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1756 | 0.140 |
Why?
|
Genetic Complementation Test | 1 | 2017 | 555 | 0.140 |
Why?
|
Mice | 16 | 2024 | 81533 | 0.140 |
Why?
|
Promoter Regions, Genetic | 2 | 2018 | 5790 | 0.140 |
Why?
|
Embryonic Stem Cells | 2 | 2021 | 1263 | 0.140 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 650 | 0.130 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2017 | 122 | 0.130 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2017 | 233 | 0.130 |
Why?
|
Lymphoma, T-Cell | 1 | 2018 | 304 | 0.130 |
Why?
|
Protein Conformation | 2 | 2022 | 3968 | 0.130 |
Why?
|
RNA-Binding Protein EWS | 1 | 2017 | 210 | 0.130 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2020 | 5305 | 0.130 |
Why?
|
Ubiquitination | 1 | 2020 | 1007 | 0.130 |
Why?
|
Transcription, Genetic | 3 | 2018 | 7593 | 0.120 |
Why?
|
RNA Splicing | 1 | 2019 | 918 | 0.120 |
Why?
|
Mutagenesis | 1 | 2018 | 1232 | 0.120 |
Why?
|
Complement C5b | 1 | 2013 | 9 | 0.120 |
Why?
|
Histone Acetyltransferases | 1 | 2016 | 336 | 0.110 |
Why?
|
Rare Diseases | 1 | 2019 | 622 | 0.110 |
Why?
|
Complement C3a | 1 | 2013 | 66 | 0.110 |
Why?
|
Injections, Intraventricular | 1 | 2013 | 225 | 0.110 |
Why?
|
HeLa Cells | 1 | 2019 | 3094 | 0.110 |
Why?
|
Antibodies | 1 | 2021 | 2418 | 0.110 |
Why?
|
Chemokine CXCL13 | 1 | 2013 | 59 | 0.110 |
Why?
|
Injections, Spinal | 1 | 2013 | 318 | 0.100 |
Why?
|
Heterozygote | 1 | 2019 | 2787 | 0.100 |
Why?
|
RNA Polymerase II | 1 | 2016 | 539 | 0.100 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1321 | 0.100 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2201 | 0.100 |
Why?
|
Organoids | 1 | 2018 | 743 | 0.100 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2013 | 326 | 0.100 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13642 | 0.100 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1459 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1509 | 0.100 |
Why?
|
Receptors, Estrogen | 1 | 2020 | 2208 | 0.100 |
Why?
|
DNA Methylation | 3 | 2024 | 4399 | 0.090 |
Why?
|
Point Mutation | 1 | 2016 | 1595 | 0.090 |
Why?
|
Phenotype | 2 | 2020 | 16592 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2192 | 0.090 |
Why?
|
Drosophila | 1 | 2018 | 1495 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1745 | 0.090 |
Why?
|
Prostate | 1 | 2018 | 1773 | 0.090 |
Why?
|
Gene Expression Profiling | 3 | 2018 | 9420 | 0.080 |
Why?
|
Saccharomyces cerevisiae | 1 | 2020 | 2688 | 0.080 |
Why?
|
DNA Replication | 1 | 2016 | 1418 | 0.080 |
Why?
|
Binding Sites | 1 | 2018 | 6056 | 0.080 |
Why?
|
Tissue Distribution | 1 | 2013 | 2264 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2021 | 2811 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2024 | 13382 | 0.080 |
Why?
|
Cell Cycle Proteins | 2 | 2020 | 3449 | 0.080 |
Why?
|
Mice, Inbred NOD | 3 | 2020 | 1827 | 0.080 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2012 | 646 | 0.080 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6534 | 0.080 |
Why?
|
STAT6 Transcription Factor | 1 | 2009 | 194 | 0.080 |
Why?
|
Models, Genetic | 1 | 2019 | 3442 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1897 | 0.080 |
Why?
|
Mice, Nude | 2 | 2019 | 3614 | 0.080 |
Why?
|
DNA Modification Methylases | 1 | 2009 | 210 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2017 | 2910 | 0.080 |
Why?
|
Adenocarcinoma | 1 | 2005 | 6346 | 0.070 |
Why?
|
Amino Acid Sequence | 1 | 2019 | 13446 | 0.070 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1974 | 0.070 |
Why?
|
Interleukin-10 | 1 | 2013 | 1175 | 0.070 |
Why?
|
Luminescent Measurements | 1 | 2009 | 342 | 0.070 |
Why?
|
DNA Repair Enzymes | 1 | 2009 | 346 | 0.070 |
Why?
|
Gene Frequency | 1 | 2013 | 3606 | 0.070 |
Why?
|
Dacarbazine | 1 | 2009 | 559 | 0.070 |
Why?
|
Methotrexate | 1 | 2012 | 1719 | 0.060 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9541 | 0.060 |
Why?
|
Genomics | 2 | 2019 | 5821 | 0.060 |
Why?
|
Cell Polarity | 1 | 2009 | 636 | 0.060 |
Why?
|
Neoplasm Transplantation | 2 | 2019 | 2016 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18253 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6032 | 0.060 |
Why?
|
Interleukin-4 | 1 | 2009 | 1149 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3537 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2020 | 2510 | 0.050 |
Why?
|
Antibodies, Monoclonal | 1 | 2020 | 9177 | 0.050 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2023 | 91 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2827 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.050 |
Why?
|
Urinary Bladder | 1 | 2009 | 1152 | 0.050 |
Why?
|
Ethanol | 1 | 2009 | 1324 | 0.050 |
Why?
|
Prognosis | 3 | 2020 | 29629 | 0.050 |
Why?
|
Germ-Line Mutation | 2 | 2024 | 1858 | 0.050 |
Why?
|
Female | 14 | 2024 | 392686 | 0.050 |
Why?
|
Male | 11 | 2020 | 360842 | 0.050 |
Why?
|
Kidney Neoplasms | 1 | 2019 | 4251 | 0.050 |
Why?
|
Signal Transduction | 3 | 2022 | 23447 | 0.050 |
Why?
|
Immunoblotting | 2 | 2020 | 1646 | 0.050 |
Why?
|
Proteomics | 2 | 2013 | 3848 | 0.050 |
Why?
|
Radiation Injuries | 1 | 2009 | 1189 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12690 | 0.050 |
Why?
|
Liver Regeneration | 1 | 2022 | 213 | 0.050 |
Why?
|
Antibody Affinity | 1 | 2021 | 246 | 0.040 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2023 | 372 | 0.040 |
Why?
|
Genetic Markers | 1 | 2006 | 2601 | 0.040 |
Why?
|
Prostate-Specific Antigen | 2 | 2009 | 2469 | 0.040 |
Why?
|
GPI-Linked Proteins | 1 | 2021 | 470 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2020 | 3603 | 0.040 |
Why?
|
Vero Cells | 1 | 2020 | 482 | 0.040 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2020 | 164 | 0.040 |
Why?
|
Breast Neoplasms | 3 | 2024 | 21017 | 0.040 |
Why?
|
Treatment Failure | 1 | 2005 | 2644 | 0.040 |
Why?
|
Lymphoma, B-Cell | 2 | 2021 | 940 | 0.040 |
Why?
|
HMGB1 Protein | 1 | 2020 | 137 | 0.040 |
Why?
|
GATA3 Transcription Factor | 1 | 2020 | 154 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2018 | 102 | 0.040 |
Why?
|
Coronavirus | 1 | 2020 | 155 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2020 | 22176 | 0.040 |
Why?
|
Azepines | 1 | 2020 | 329 | 0.040 |
Why?
|
Receptors, IgG | 1 | 2021 | 559 | 0.040 |
Why?
|
Guanosine Triphosphate | 1 | 2018 | 316 | 0.040 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2018 | 187 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2020 | 852 | 0.040 |
Why?
|
Immunoprecipitation | 1 | 2020 | 878 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2020 | 3639 | 0.040 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1705 | 0.040 |
Why?
|
Cells, Cultured | 1 | 2013 | 18965 | 0.040 |
Why?
|
Electrophoresis, Agar Gel | 1 | 2017 | 207 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 561 | 0.030 |
Why?
|
Transcription Initiation Site | 1 | 2017 | 188 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 720 | 0.030 |
Why?
|
Survival Rate | 3 | 2020 | 12725 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 615 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2009 | 4028 | 0.030 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2021 | 774 | 0.030 |
Why?
|
Antioxidants | 1 | 2023 | 1668 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2017 | 784 | 0.030 |
Why?
|
Neuroglia | 1 | 2020 | 956 | 0.030 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58986 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5672 | 0.030 |
Why?
|
Triazoles | 1 | 2020 | 903 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 1971 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 871 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2020 | 1014 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2017 | 855 | 0.030 |
Why?
|
Ubiquitin | 1 | 2019 | 839 | 0.030 |
Why?
|
Middle Aged | 7 | 2020 | 220920 | 0.030 |
Why?
|
Macrophages | 1 | 2009 | 5769 | 0.030 |
Why?
|
Rabbits | 1 | 2020 | 4772 | 0.030 |
Why?
|
Combined Modality Therapy | 1 | 2005 | 8528 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2021 | 11904 | 0.030 |
Why?
|
Infusions, Intraventricular | 1 | 2012 | 32 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2018 | 988 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 733 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2018 | 3076 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2018 | 1342 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3162 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2018 | 3597 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2822 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2020 | 1745 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2018 | 1844 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1486 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2020 | 1712 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2919 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 2020 | 1699 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2020 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1334 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2021 | 2557 | 0.020 |
Why?
|
Cell Cycle | 1 | 2019 | 2932 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2019 | 2448 | 0.020 |
Why?
|
Gene Expression | 1 | 2023 | 7581 | 0.020 |
Why?
|
Epigenomics | 1 | 2016 | 943 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1440 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14666 | 0.020 |
Why?
|
Chemotaxis | 1 | 2013 | 598 | 0.020 |
Why?
|
Sirolimus | 1 | 2017 | 1533 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2450 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3430 | 0.020 |
Why?
|
Adult | 5 | 2020 | 221203 | 0.020 |
Why?
|
Aged | 4 | 2020 | 169310 | 0.020 |
Why?
|
Zebrafish | 1 | 2020 | 3007 | 0.020 |
Why?
|
Goserelin | 1 | 2009 | 126 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5791 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2872 | 0.020 |
Why?
|
Infant | 2 | 2020 | 36192 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6484 | 0.020 |
Why?
|
Mice, SCID | 1 | 2013 | 2626 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6864 | 0.020 |
Why?
|
Antithrombin III | 1 | 2007 | 128 | 0.020 |
Why?
|
Genetic Loci | 1 | 2017 | 2632 | 0.020 |
Why?
|
Child, Preschool | 2 | 2020 | 42230 | 0.020 |
Why?
|
Eye Neoplasms | 1 | 2009 | 307 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2017 | 1642 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15601 | 0.020 |
Why?
|
Fibroblasts | 1 | 2017 | 4141 | 0.020 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2007 | 178 | 0.020 |
Why?
|
Drug Therapy | 1 | 2009 | 503 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 506 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4575 | 0.020 |
Why?
|
Blotting, Western | 1 | 2013 | 5035 | 0.020 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2009 | 547 | 0.020 |
Why?
|
Genetic Variation | 1 | 2020 | 6567 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2013 | 6132 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 88324 | 0.010 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 694 | 0.010 |
Why?
|
Chromatography, Liquid | 1 | 2007 | 983 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8466 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7047 | 0.010 |
Why?
|
Inflammation | 1 | 2023 | 10773 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2009 | 12975 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20099 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2009 | 1264 | 0.010 |
Why?
|
Radiotherapy | 1 | 2009 | 1499 | 0.010 |
Why?
|
Child | 2 | 2020 | 80156 | 0.010 |
Why?
|
Neurons | 1 | 2020 | 9463 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10194 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2009 | 1520 | 0.010 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1600 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29876 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3810 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 22172 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39107 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 12794 | 0.010 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2007 | 1405 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41493 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 39970 | 0.010 |
Why?
|
Immunotherapy | 1 | 2009 | 4652 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59255 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 20571 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 74213 | 0.000 |
Why?
|